GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
7.64
-0.28 (-3.54%)
Mar 3, 2025, 4:00 PM EST - Market closed
GRI Bio Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 4.32 | 8.16 | 2 | 0.81 | 1.2 |
| Research & Development | 3.99 | 3.23 | 0.24 | 0.25 | 0.26 |
| Other Operating Expenses | - | -0.25 | - | - | - |
| Operating Expenses | 8.31 | 11.14 | 2.24 | 1.06 | 1.46 |
| Operating Income | -8.31 | -11.14 | -2.24 | -1.06 | -1.46 |
| Interest Expense | - | -2.08 | -0.65 | -0.55 | -1.07 |
| Other Non Operating Income (Expenses) | 0.02 | 0.18 | - | - | - |
| EBT Excluding Unusual Items | -8.26 | -13.04 | -2.89 | -1.61 | -2.53 |
| Other Unusual Items | - | - | -0.33 | 0.05 | - |
| Pretax Income | -8.26 | -13.04 | -3.22 | -1.56 | -2.53 |
| Net Income | -8.26 | -13.04 | -3.22 | -1.56 | -2.53 |
| Net Income to Common | -8.26 | -13.04 | -3.22 | -1.56 | -2.53 |
| Shares Outstanding (Basic) | 0 | - | - | 0 | 0 |
| Shares Outstanding (Diluted) | 0 | - | - | 0 | 0 |
| Shares Change (YoY) | - | - | - | 2.26% | - |
| EPS (Basic) | -134.26 | - | - | -100.97 | -167.63 |
| EPS (Diluted) | -134.26 | - | - | -100.97 | -167.63 |
| Free Cash Flow | -12.17 | -9 | -1.09 | -0.85 | -0.83 |
| Free Cash Flow Per Share | -197.78 | - | - | -54.86 | -55.04 |
| EBITDA | -8.3 | -11.13 | -2.24 | -1.06 | -1.46 |
| D&A For EBITDA | 0 | 0 | 0 | 0 | 0 |
| EBIT | -8.31 | -11.14 | -2.24 | -1.06 | -1.46 |
Source: S&P Capital IQ. Standard template.
Financial Sources.